BACKGROUND: The aim of this case study was to investigate the safety and efficacy of the SONG Laser Protocol in the context of dementia. Our hypothesis is that the SONG Laser Protocol, when administered intravenously, may have a beneficial effect on the alpha waves [as assessed by electroencephalography (EEG)] in a patient suffering from dementia.
CASE REPORT: This was a case study focusing on a single patient suffering from dementia. The SONG Laser Protocol was delivered in a clinical setting, and the primary outcome measures were the amplitude of alpha waves as seen in EEG, the target frequency of the alpha waves, and the power spectrum density.
The pre- and post-SONG Laser Protocol EEGs were compared. A clear increase in alpha wave activity on Day 3 post-SONG Laser Protocol was detected. The alpha wave target frequency increased to 8.0 (normal range 8.0-12.0), and the power spectrum density (PSD) increased by 65%. The patient also expressed feelings of improved well-being following the SONG Laser Protocol.
CONCLUSIONS: The SONG Laser Protocol may have a beneficial effect on alpha wave activity in a patient suffering from dementia. Clinical trials are needed to confirm safety and efficacy.